Prostate Cancer - Results from #24340

Treatment of chemotherapy-naive metastatic castration-resistant prostate cancer - Case Lecture Presentation November 26, 2012

Metabolic impact of androgen deprivation therapy for prostate cancer - Abstract November 26, 2012

MRI-guided targeted prostate biopsies in the diagnosis of prostate cancer: A systematic literature review - Abstract November 24, 2012

Diagnostic performance of contrast enhanced ultrasound in patients with prostate cancer: A meta-analysis - Abstract November 24, 2012

25 Year disease free survival rate after irradiation of prostate cancer calculated with the prostate specific antigen definition of recurrence used for radical prostatectomy - Abstract November 24, 2012

A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human αν integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate c November 24, 2012

Are Partin tables suitable for Chinese patients with prostate cancer? - Abstract November 24, 2012

Diagnostic tests in urology: Percentage of free prostate-specific antigen (PSA) - Abstract November 24, 2012

Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: An international comparison - Abstract November 24, 2012

Repeat transrectal prostate biopsies in diagnosing prostate cancer - Abstract November 23, 2012

Hormone replacement therapy in prostate cancer: Side effects and their management - Abstract November 23, 2012

The natural history of penile length after radical prostatectomy: A long-term prospective study - Abstract November 23, 2012

Out-of-pocket expenses and treatment choice for men with prostate cancer - Abstract November 23, 2012

National Prostate Cancer Registry 2010 in Spain - Abstract November 23, 2012

Long-term control of refractory hemorrhagic radiation proctitis with ozone therapy - Abstract November 23, 2012

PSA response to neoadjuvant androgen deprivation therapy is a strong independent predictor of survival in high-risk prostate cancer in the dose-escalated radiation therapy era - Abstract November 23, 2012

Interstitial brachytherapy in localised prostate cancer: Executive summary of final report N04-02, Version 1.0 - Abstract November 22, 2012

The lived experience of men diagnosed with prostate cancer - Abstract November 22, 2012

The changing landscape of treatment options for metastatic castrate-resistant prostate cancer: Challenges and solutions for physicians and patients - Abstract November 22, 2012

Cabazitaxel in metastatic castration-resistant prostate cancer - Abstract November 22, 2012

Page 1218 of 1436